| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2566196 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2009 | 8 Pages |
Abstract
PurposeA growing body of research supports an important role for GABA in the pathophysiology of bipolar and other mood disorders. The purpose of the current study was to directly examine brain GABA levels in a clinical sample of bipolar patients.General methodsWe used magnetic resonance spectroscopy (MRS) to examine whole brain and regional GABA, glutamate and glutamine in 13 patients with bipolar disorder compared to a matched group of 11 healthy controls.FindingsThere were no significant differences in GABA, glutamate or glutamine between patients and controls.ConclusionsFurther research is needed to better characterize the GABAergic and glutamatergic effects of pharmacotherapy, anxiety comorbidity and clinical state in bipolar disorder.
Keywords
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Rebecca E. Kaufman, Michael J. Ostacher, Elizabeth H. Marks, Naomi M. Simon, Gary S. Sachs, J. Eric Jensen, Perry F. Renshaw, Mark H. Pollack,